Loading…

Control of Oxidative Reactions of Hemoglobin in the Design of Blood Substitutes: Role of the Ascorbate-Glutathione Antioxidant System

Uncontrolled oxidative reactions of hemoglobin (Hb) are still the main unresolved problem for Hb‐based blood substitute developers. Spontaneous oxidation of acellular ferrous Hb into a nonfunctional ferric Hb generates superoxide anion. Hydrogen peroxide, formed after superoxide anion dismutation, m...

Full description

Saved in:
Bibliographic Details
Published in:Artificial organs 2009-02, Vol.33 (2), p.115-126
Main Authors: Simoni, Jan, Villanueva-Meyer, Javier, Simoni, Grace, Moeller, John F., Wesson, Donald E.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5325-7b744cbc471a5db5090eeafb4b02e6f4aaaae6dc84dbec2e516781d2170988803
cites cdi_FETCH-LOGICAL-c5325-7b744cbc471a5db5090eeafb4b02e6f4aaaae6dc84dbec2e516781d2170988803
container_end_page 126
container_issue 2
container_start_page 115
container_title Artificial organs
container_volume 33
creator Simoni, Jan
Villanueva-Meyer, Javier
Simoni, Grace
Moeller, John F.
Wesson, Donald E.
description Uncontrolled oxidative reactions of hemoglobin (Hb) are still the main unresolved problem for Hb‐based blood substitute developers. Spontaneous oxidation of acellular ferrous Hb into a nonfunctional ferric Hb generates superoxide anion. Hydrogen peroxide, formed after superoxide anion dismutation, may react with ferrous/ferric Hb to produce toxic ferryl Hb, fluorescent heme degradation products, and/or protein‐based free radicals. In the presence of free iron released from heme, superoxide anion and hydrogen peroxide might react via the Haber–Weiss and Fenton reactions to generate the hydroxyl radical. These highly reactive oxygen and heme species may not only be involved in shifting the cellular redox balance to the oxidized state that facilitates signal transduction and pro‐inflammatory gene expression, but could also be involved in cellular and organ injury, and generation of vasoactive compounds such as isoprostanes and angiotensins. It is believed that these toxic species may be formed after administration of Hb‐based blood substitutes, particularly in ischemic patients with a diminished ability to control oxidative reactions. Although varieties of antioxidant strategies have been suggested, this in vitro study examined the ability of the ascorbate–glutathione antioxidant system in preventing Hb oxidation and formation of its ferryl intermediate. The results suggest that although ascorbate is effective in reducing the formation of ferryl Hb, glutathione protects heme against excessive oxidation. Ascorbate without glutathione failed to protect the red blood cell membranes against Hb/hydrogen peroxide‐mediated peroxidation. This study provides evidence that the ascorbate–glutathione antioxidant system is essential in attenuation of the pro‐oxidant potential of redox active acellular Hbs, and superior to either ascorbate or glutathione alone.
doi_str_mv 10.1111/j.1525-1594.2008.00695.x
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_20400151</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20062773</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5325-7b744cbc471a5db5090eeafb4b02e6f4aaaae6dc84dbec2e516781d2170988803</originalsourceid><addsrcrecordid>eNqNUd1u0zAUthCIdYNXQLniLuE4seMEcVMKdKBCpQbE7iw7Odlc0niLndE-AO-NQ6txuyNLPjrfz5H9ERJRSGioN9uE8pTHlJcsSQGKBCAvebJ_QmYPwFMyA5pDzHN2dUbOndsCgGCQPydntKSiYJzPyJ-F7f1gu8i20XpvGuXNPUYbVLU3tnfT-BJ39rqz2vRROP4Gow_ozHU_Ye87a5uoGrXzxo8e3dtoYzucoIk4d7UdtPIYL7vRK38TPMO0D97Trt5H1cF53L0gz1rVOXx5ui_Ij08fvy8u49V6-XkxX8U1z8KzhBaM1bpmgireaA4lIKpWMw0p5i1ToTBv6oI1GusUOc1FQZuUCiiLooDsgrw--t4O9m5E5-XOuBq7TvVoRydTYACU00cQIU-FyAKxOBLrwTo3YCtvB7NTw0FSkFNWciunSOQUySQr5L-s5D5IX512jHqHzX_hKZxAeHck_DYdHh5tLOfrTWiCPD7KTfji_YNcDb9kLjLB5c9vS1l9rSpWrb7Iq-wvNpCz3w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20062773</pqid></control><display><type>article</type><title>Control of Oxidative Reactions of Hemoglobin in the Design of Blood Substitutes: Role of the Ascorbate-Glutathione Antioxidant System</title><source>Wiley</source><creator>Simoni, Jan ; Villanueva-Meyer, Javier ; Simoni, Grace ; Moeller, John F. ; Wesson, Donald E.</creator><creatorcontrib>Simoni, Jan ; Villanueva-Meyer, Javier ; Simoni, Grace ; Moeller, John F. ; Wesson, Donald E.</creatorcontrib><description>Uncontrolled oxidative reactions of hemoglobin (Hb) are still the main unresolved problem for Hb‐based blood substitute developers. Spontaneous oxidation of acellular ferrous Hb into a nonfunctional ferric Hb generates superoxide anion. Hydrogen peroxide, formed after superoxide anion dismutation, may react with ferrous/ferric Hb to produce toxic ferryl Hb, fluorescent heme degradation products, and/or protein‐based free radicals. In the presence of free iron released from heme, superoxide anion and hydrogen peroxide might react via the Haber–Weiss and Fenton reactions to generate the hydroxyl radical. These highly reactive oxygen and heme species may not only be involved in shifting the cellular redox balance to the oxidized state that facilitates signal transduction and pro‐inflammatory gene expression, but could also be involved in cellular and organ injury, and generation of vasoactive compounds such as isoprostanes and angiotensins. It is believed that these toxic species may be formed after administration of Hb‐based blood substitutes, particularly in ischemic patients with a diminished ability to control oxidative reactions. Although varieties of antioxidant strategies have been suggested, this in vitro study examined the ability of the ascorbate–glutathione antioxidant system in preventing Hb oxidation and formation of its ferryl intermediate. The results suggest that although ascorbate is effective in reducing the formation of ferryl Hb, glutathione protects heme against excessive oxidation. Ascorbate without glutathione failed to protect the red blood cell membranes against Hb/hydrogen peroxide‐mediated peroxidation. This study provides evidence that the ascorbate–glutathione antioxidant system is essential in attenuation of the pro‐oxidant potential of redox active acellular Hbs, and superior to either ascorbate or glutathione alone.</description><identifier>ISSN: 0160-564X</identifier><identifier>EISSN: 1525-1594</identifier><identifier>DOI: 10.1111/j.1525-1594.2008.00695.x</identifier><identifier>PMID: 19178455</identifier><language>eng</language><publisher>Malden, USA: Blackwell Publishing Inc</publisher><subject>Animals ; Ascorbate ; Ascorbic Acid - pharmacology ; Blood substitute ; Blood Substitutes - chemistry ; Blood Substitutes - metabolism ; Cattle ; Drug Design ; Erythrocyte Membrane - drug effects ; Glutathione ; Glutathione - pharmacology ; Heme - metabolism ; Hemoglobin ; Humans ; Hydrogen Peroxide ; Lipid Peroxidation - drug effects ; Oxidation-Reduction ; Oxidative reactions</subject><ispartof>Artificial organs, 2009-02, Vol.33 (2), p.115-126</ispartof><rights>2009, Copyright the Authors. Journal compilation © 2009, International Center for Artificial Organs and Transplantation and Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5325-7b744cbc471a5db5090eeafb4b02e6f4aaaae6dc84dbec2e516781d2170988803</citedby><cites>FETCH-LOGICAL-c5325-7b744cbc471a5db5090eeafb4b02e6f4aaaae6dc84dbec2e516781d2170988803</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19178455$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Simoni, Jan</creatorcontrib><creatorcontrib>Villanueva-Meyer, Javier</creatorcontrib><creatorcontrib>Simoni, Grace</creatorcontrib><creatorcontrib>Moeller, John F.</creatorcontrib><creatorcontrib>Wesson, Donald E.</creatorcontrib><title>Control of Oxidative Reactions of Hemoglobin in the Design of Blood Substitutes: Role of the Ascorbate-Glutathione Antioxidant System</title><title>Artificial organs</title><addtitle>Artif Organs</addtitle><description>Uncontrolled oxidative reactions of hemoglobin (Hb) are still the main unresolved problem for Hb‐based blood substitute developers. Spontaneous oxidation of acellular ferrous Hb into a nonfunctional ferric Hb generates superoxide anion. Hydrogen peroxide, formed after superoxide anion dismutation, may react with ferrous/ferric Hb to produce toxic ferryl Hb, fluorescent heme degradation products, and/or protein‐based free radicals. In the presence of free iron released from heme, superoxide anion and hydrogen peroxide might react via the Haber–Weiss and Fenton reactions to generate the hydroxyl radical. These highly reactive oxygen and heme species may not only be involved in shifting the cellular redox balance to the oxidized state that facilitates signal transduction and pro‐inflammatory gene expression, but could also be involved in cellular and organ injury, and generation of vasoactive compounds such as isoprostanes and angiotensins. It is believed that these toxic species may be formed after administration of Hb‐based blood substitutes, particularly in ischemic patients with a diminished ability to control oxidative reactions. Although varieties of antioxidant strategies have been suggested, this in vitro study examined the ability of the ascorbate–glutathione antioxidant system in preventing Hb oxidation and formation of its ferryl intermediate. The results suggest that although ascorbate is effective in reducing the formation of ferryl Hb, glutathione protects heme against excessive oxidation. Ascorbate without glutathione failed to protect the red blood cell membranes against Hb/hydrogen peroxide‐mediated peroxidation. This study provides evidence that the ascorbate–glutathione antioxidant system is essential in attenuation of the pro‐oxidant potential of redox active acellular Hbs, and superior to either ascorbate or glutathione alone.</description><subject>Animals</subject><subject>Ascorbate</subject><subject>Ascorbic Acid - pharmacology</subject><subject>Blood substitute</subject><subject>Blood Substitutes - chemistry</subject><subject>Blood Substitutes - metabolism</subject><subject>Cattle</subject><subject>Drug Design</subject><subject>Erythrocyte Membrane - drug effects</subject><subject>Glutathione</subject><subject>Glutathione - pharmacology</subject><subject>Heme - metabolism</subject><subject>Hemoglobin</subject><subject>Humans</subject><subject>Hydrogen Peroxide</subject><subject>Lipid Peroxidation - drug effects</subject><subject>Oxidation-Reduction</subject><subject>Oxidative reactions</subject><issn>0160-564X</issn><issn>1525-1594</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNqNUd1u0zAUthCIdYNXQLniLuE4seMEcVMKdKBCpQbE7iw7Odlc0niLndE-AO-NQ6txuyNLPjrfz5H9ERJRSGioN9uE8pTHlJcsSQGKBCAvebJ_QmYPwFMyA5pDzHN2dUbOndsCgGCQPydntKSiYJzPyJ-F7f1gu8i20XpvGuXNPUYbVLU3tnfT-BJ39rqz2vRROP4Gow_ozHU_Ye87a5uoGrXzxo8e3dtoYzucoIk4d7UdtPIYL7vRK38TPMO0D97Trt5H1cF53L0gz1rVOXx5ui_Ij08fvy8u49V6-XkxX8U1z8KzhBaM1bpmgireaA4lIKpWMw0p5i1ToTBv6oI1GusUOc1FQZuUCiiLooDsgrw--t4O9m5E5-XOuBq7TvVoRydTYACU00cQIU-FyAKxOBLrwTo3YCtvB7NTw0FSkFNWciunSOQUySQr5L-s5D5IX512jHqHzX_hKZxAeHck_DYdHh5tLOfrTWiCPD7KTfji_YNcDb9kLjLB5c9vS1l9rSpWrb7Iq-wvNpCz3w</recordid><startdate>200902</startdate><enddate>200902</enddate><creator>Simoni, Jan</creator><creator>Villanueva-Meyer, Javier</creator><creator>Simoni, Grace</creator><creator>Moeller, John F.</creator><creator>Wesson, Donald E.</creator><general>Blackwell Publishing Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>200902</creationdate><title>Control of Oxidative Reactions of Hemoglobin in the Design of Blood Substitutes: Role of the Ascorbate-Glutathione Antioxidant System</title><author>Simoni, Jan ; Villanueva-Meyer, Javier ; Simoni, Grace ; Moeller, John F. ; Wesson, Donald E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5325-7b744cbc471a5db5090eeafb4b02e6f4aaaae6dc84dbec2e516781d2170988803</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Animals</topic><topic>Ascorbate</topic><topic>Ascorbic Acid - pharmacology</topic><topic>Blood substitute</topic><topic>Blood Substitutes - chemistry</topic><topic>Blood Substitutes - metabolism</topic><topic>Cattle</topic><topic>Drug Design</topic><topic>Erythrocyte Membrane - drug effects</topic><topic>Glutathione</topic><topic>Glutathione - pharmacology</topic><topic>Heme - metabolism</topic><topic>Hemoglobin</topic><topic>Humans</topic><topic>Hydrogen Peroxide</topic><topic>Lipid Peroxidation - drug effects</topic><topic>Oxidation-Reduction</topic><topic>Oxidative reactions</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Simoni, Jan</creatorcontrib><creatorcontrib>Villanueva-Meyer, Javier</creatorcontrib><creatorcontrib>Simoni, Grace</creatorcontrib><creatorcontrib>Moeller, John F.</creatorcontrib><creatorcontrib>Wesson, Donald E.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Artificial organs</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Simoni, Jan</au><au>Villanueva-Meyer, Javier</au><au>Simoni, Grace</au><au>Moeller, John F.</au><au>Wesson, Donald E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Control of Oxidative Reactions of Hemoglobin in the Design of Blood Substitutes: Role of the Ascorbate-Glutathione Antioxidant System</atitle><jtitle>Artificial organs</jtitle><addtitle>Artif Organs</addtitle><date>2009-02</date><risdate>2009</risdate><volume>33</volume><issue>2</issue><spage>115</spage><epage>126</epage><pages>115-126</pages><issn>0160-564X</issn><eissn>1525-1594</eissn><abstract>Uncontrolled oxidative reactions of hemoglobin (Hb) are still the main unresolved problem for Hb‐based blood substitute developers. Spontaneous oxidation of acellular ferrous Hb into a nonfunctional ferric Hb generates superoxide anion. Hydrogen peroxide, formed after superoxide anion dismutation, may react with ferrous/ferric Hb to produce toxic ferryl Hb, fluorescent heme degradation products, and/or protein‐based free radicals. In the presence of free iron released from heme, superoxide anion and hydrogen peroxide might react via the Haber–Weiss and Fenton reactions to generate the hydroxyl radical. These highly reactive oxygen and heme species may not only be involved in shifting the cellular redox balance to the oxidized state that facilitates signal transduction and pro‐inflammatory gene expression, but could also be involved in cellular and organ injury, and generation of vasoactive compounds such as isoprostanes and angiotensins. It is believed that these toxic species may be formed after administration of Hb‐based blood substitutes, particularly in ischemic patients with a diminished ability to control oxidative reactions. Although varieties of antioxidant strategies have been suggested, this in vitro study examined the ability of the ascorbate–glutathione antioxidant system in preventing Hb oxidation and formation of its ferryl intermediate. The results suggest that although ascorbate is effective in reducing the formation of ferryl Hb, glutathione protects heme against excessive oxidation. Ascorbate without glutathione failed to protect the red blood cell membranes against Hb/hydrogen peroxide‐mediated peroxidation. This study provides evidence that the ascorbate–glutathione antioxidant system is essential in attenuation of the pro‐oxidant potential of redox active acellular Hbs, and superior to either ascorbate or glutathione alone.</abstract><cop>Malden, USA</cop><pub>Blackwell Publishing Inc</pub><pmid>19178455</pmid><doi>10.1111/j.1525-1594.2008.00695.x</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0160-564X
ispartof Artificial organs, 2009-02, Vol.33 (2), p.115-126
issn 0160-564X
1525-1594
language eng
recordid cdi_proquest_miscellaneous_20400151
source Wiley
subjects Animals
Ascorbate
Ascorbic Acid - pharmacology
Blood substitute
Blood Substitutes - chemistry
Blood Substitutes - metabolism
Cattle
Drug Design
Erythrocyte Membrane - drug effects
Glutathione
Glutathione - pharmacology
Heme - metabolism
Hemoglobin
Humans
Hydrogen Peroxide
Lipid Peroxidation - drug effects
Oxidation-Reduction
Oxidative reactions
title Control of Oxidative Reactions of Hemoglobin in the Design of Blood Substitutes: Role of the Ascorbate-Glutathione Antioxidant System
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T16%3A02%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Control%20of%20Oxidative%20Reactions%20of%20Hemoglobin%20in%20the%20Design%20of%20Blood%20Substitutes:%20Role%20of%20the%20Ascorbate-Glutathione%20Antioxidant%20System&rft.jtitle=Artificial%20organs&rft.au=Simoni,%20Jan&rft.date=2009-02&rft.volume=33&rft.issue=2&rft.spage=115&rft.epage=126&rft.pages=115-126&rft.issn=0160-564X&rft.eissn=1525-1594&rft_id=info:doi/10.1111/j.1525-1594.2008.00695.x&rft_dat=%3Cproquest_cross%3E20062773%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5325-7b744cbc471a5db5090eeafb4b02e6f4aaaae6dc84dbec2e516781d2170988803%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=20062773&rft_id=info:pmid/19178455&rfr_iscdi=true